The Leadership Team at Aro Biotherapeutics is responsible for setting the strategic vision and direction of the company, guiding the development of innovative tissue-targeted genetic medicines. This diverse group, comprised of experts in finance, scientific research, legal affairs, and technology, collaborates to drive business growth, ensure regulatory compliance, and foster scientific advancements that leverage the proprietary Centyrin technology. Together, they oversee all facets of operations, from financial planning to clinical research, aiming to unlock the full potential of genetic therapies.
View all